February 24, 2021Open Access

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Key Points

Key points are not available for this paper at this time.

Abstract

This study in a nationwide mass vaccination setting suggests that the BNT162b2 mRNA vaccine is effective for a wide range of Covid-19-related outcomes, a finding consistent with that of the randomized trial.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Dagan et al. (Wed,) studied this question.

synapsesocial.com/papers/69de9d3b40ea065679558bfb — DOI: https://doi.org/10.1056/nejmoa2101765

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020· 2020 · 1,260 citations
Negative Controls· 2010 · 1,471 citations
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine· 2020 · 15,477 citations
Postexposure Effects of Vaccines on Infectious Diseases· 2019 · 37 citations
Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant· 2021 · 255 citations

Authors

Noa Dagan

Ben-Gurion University of the Negev

Noam Barda

Ben-Gurion University of the Negev

Eldad Kepten

Clalit Health Services

Journals

New England Journal of Medicine

Actions

Institutions

Clalit Health Services

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Also consider